West Pharmaceutical Services Inc Total Liabilities
West Pharmaceutical Services Inc total liabilities. Based on the latest financial reports, West Pharmaceutical Services Inc (WST) has total liabilities worth $1.12 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check West Pharmaceutical Services Inc (WST) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of West Pharmaceutical Services Inc (1985–2025)
Total liabilities of West Pharmaceutical Services Inc from 1985 to 2025. This chart illustrates how West Pharmaceutical Services Inc's total liabilities have evolved over time, based on quarterly financial data. Explore WST long-term investments to assets to see how much of total assets are deployed in long-term investments.
West Pharmaceutical Services Inc Competitors by Total Liabilities
The table below lists competitors of West Pharmaceutical Services Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ABN AMRO BK.UNSP.ADR/1
F:AB2A
|
Germany | €429.65 Billion |
|
Grasim Industries Limited
NSE:GRASIM
|
India | Rs3.68 Trillion |
|
Cathay Financial Holding Co Ltd Pref A
TW:2882A
|
Taiwan | NT$13.41 Trillion |
|
Alfa Laval AB
ST:ALFA
|
Sweden | Skr58.89 Billion |
|
Shanxi Xinghuacun Fen Wine Factory Co Ltd
SHG:600809
|
China | CN¥25.05 Billion |
|
GigaDevice Semiconductor(Beiji
SHG:603986
|
China | CN¥2.26 Billion |
|
First Citizens BancShares, Inc.
NASDAQ:FCNCA
|
USA | $214.94 Billion |
|
Omnicom Group Inc
NYSE:OMC
|
USA | $39.63 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down West Pharmaceutical Services Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see WST asset base.
Liquidity & Leverage Metrics
West Pharmaceutical Services Inc Total Liabilities Ratios Explained
West Pharmaceutical Services Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how West Pharmaceutical Services Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for West Pharmaceutical Services Inc (1985–2025)
The table below shows the annual total liabilities of West Pharmaceutical Services Inc from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.09 Billion | +13.83% |
| 2024-12-31 | $961.10 Million | +1.33% |
| 2023-12-31 | $948.50 Million | +1.78% |
| 2022-12-31 | $931.90 Million | -4.75% |
| 2021-12-31 | $978.40 Million | +4.16% |
| 2020-12-31 | $939.30 Million | +22.27% |
| 2019-12-31 | $768.20 Million | +31.86% |
| 2018-12-31 | $582.60 Million | +195.74% |
| 2017-12-31 | $197.00 Million | -67.12% |
| 2016-12-31 | $599.20 Million | -10.73% |
| 2015-12-31 | $671.20 Million | -5.84% |
| 2014-12-31 | $712.80 Million | -6.85% |
| 2013-12-31 | $765.20 Million | -8.37% |
| 2012-12-31 | $835.10 Million | +12.21% |
| 2011-12-31 | $744.20 Million | +11.31% |
| 2010-12-31 | $668.60 Million | -3.37% |
| 2009-12-31 | $691.90 Million | +1.51% |
| 2008-12-31 | $681.60 Million | -1.89% |
| 2007-12-31 | $694.70 Million | +39.25% |
| 2006-12-31 | $498.90 Million | +1.92% |
| 2005-12-31 | $489.50 Million | +40.62% |
| 2004-12-31 | $348.10 Million | -4.89% |
| 2003-12-31 | $366.00 Million | +11.55% |
| 2002-12-31 | $328.10 Million | -1.91% |
| 2001-12-31 | $334.50 Million | -2.56% |
| 2000-12-31 | $343.30 Million | +7.35% |
| 1999-12-31 | $319.80 Million | +15.28% |
| 1998-12-31 | $277.40 Million | +38.84% |
| 1997-12-31 | $199.80 Million | -11.24% |
| 1996-12-31 | $225.10 Million | -0.31% |
| 1995-12-31 | $225.80 Million | +34.24% |
| 1994-12-31 | $168.20 Million | +55.17% |
| 1993-12-31 | $108.40 Million | -13.76% |
| 1992-12-31 | $125.70 Million | -17.36% |
| 1991-12-31 | $152.10 Million | -2.31% |
| 1990-12-31 | $155.70 Million | +25.36% |
| 1989-12-31 | $124.20 Million | -2.59% |
| 1988-12-31 | $127.50 Million | +2.57% |
| 1987-12-31 | $124.30 Million | +26.19% |
| 1986-12-31 | $98.50 Million | +65.55% |
| 1985-12-31 | $59.50 Million | -- |
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; sy… Read more